Pedroncelli AM - Search Results

1

Gender- and age-related differences in the endocrine parameters of acromegaly.

Colao A, Amato G, Pedroncelli AM, Baldelli R, Grottoli S, Gasco V, Petretta M, Carella C, Pagani G, Tambura G, Lombardi G. Colao A, et al. Among authors: pedroncelli am. J Endocrinol Invest. 2002 Jun;25(6):532-8. doi: 10.1007/BF03345496. J Endocrinol Invest. 2002. PMID: 12109625

2

A new oral slow release form of bromocriptine, Parlodel SRO, in the chronic treatment of 26 hyperprolactinemic patients.

Gianola D, Pedroncelli A, Montini M, Tengattini F, Pagani MD, Cortesi L, Cappi MP, Gherardi F, Lancranjan I, Pagani G. Gianola D, et al. Gynecol Endocrinol. 1991 Sep;5(3):213-6. doi: 10.3109/09513599109028443. Gynecol Endocrinol. 1991. PMID: 1776507 Free article.

3

Medical management of acromegaly: effects of SMS 201-995 in 30 patients.

Pagani G, Montini M, Gianola D, Pagani MD, Tengattini F, Dominoni P, Ghilardi G, Cortesi L, Pedroncelli A, Tonnarelli GP. Pagani G, et al. Endocrinol Exp. 1990 Mar;24(1-2):175-85. Endocrinol Exp. 1990. PMID: 2361459

4

Insulin secretion and glucose tolerance in non-insulin dependent diabetic patients after chronic nifedipine treatment.

Tentorio A, Ghilardi G, Pedroncelli A, Benco R, Stroppa S, Adib S, Gianola D, Pagani G. Tentorio A, et al. Eur J Clin Pharmacol. 1989;36(3):311-3. doi: 10.1007/BF00558165. Eur J Clin Pharmacol. 1989. PMID: 2663524

5

Cholelithiasis and acromegaly: therapeutic strategies.

Montini M, Gianola D, Pagani MD, Pedroncelli A, Caldara R, Gherardi F, Bonelli M, Lancranjan I, Pagani G. Montini M, et al. Clin Endocrinol (Oxf). 1994 Mar;40(3):401-6. doi: 10.1111/j.1365-2265.1994.tb03938.x. Clin Endocrinol (Oxf). 1994. PMID: 8187305

6

Growth hormone binding protein and growth hormone availability in acromegalic patients treated with long-acting octreotide (Sandostatin-LAR).

Fisker S, Kaal A, Montini M, Pedroncelli A, Pagani G, Orskov H. Fisker S, et al. Eur J Endocrinol. 1997 Jan;136(1):61-6. doi: 10.1530/eje.0.1360061. Eur J Endocrinol. 1997. PMID: 9037128 Clinical Trial.

7

Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients.

Verhelst JA, Pedroncelli AM, Abs R, Montini M, Vandeweghe MV, Albani G, Maiter D, Pagani MD, Legros JJ, Gianola D, Bex M, Poppe K, Mockel J, Pagani G. Verhelst JA, et al. Among authors: pedroncelli am. Eur J Endocrinol. 2000 Nov;143(5):577-84. doi: 10.1530/eje.0.1430577. Eur J Endocrinol. 2000. PMID: 11078980 Clinical Trial.

8

Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?

Cozzi R, Attanasio R, Montini M, Pagani G, Lasio G, Lodrini S, Barausse M, Albizzi M, Dallabonzana D, Pedroncelli AM. Cozzi R, et al. Among authors: pedroncelli am. J Clin Endocrinol Metab. 2003 Jul;88(7):3090-8. doi: 10.1210/jc.2003-030110. J Clin Endocrinol Metab. 2003. PMID: 12843148

9

The effects of somatostatin analogs on tumor shrinkage in acromegaly.

Pedroncelli AM, Montini M, Albizzi M, Barbò R, Pagani G. Pedroncelli AM, et al. J Endocrinol Invest. 2003;26(8 Suppl):50-4. J Endocrinol Invest. 2003. PMID: 15233213 Review. No abstract available.

10

Treatment of acromegaly with SS analogues: should GH and IGF-I target levels be lowered to assert a tight control of the disease?

Cozzi R, Attanasio R, Grottoli S, Pagani G, Loli P, Gasco V, Pedroncelli AM, Montini M, Ghigo E. Cozzi R, et al. Among authors: pedroncelli am. J Endocrinol Invest. 2004 Dec;27(11):1040-7. doi: 10.1007/BF03345307. J Endocrinol Invest. 2004. PMID: 15754736 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters